Silicon Valley’s next risky self-optimization craze is unproven peptides

Photo credit: Яна via Pixabay. Article by Skye Jacobs. TechSpot – January 5, 2026.

Biohacking: On the fringes of the tech industry, the use of peptides has expanded far beyond the GLP-1 agonists that have transformed the science of weight loss. A diverse array of compounds is now in circulation, each promoted by enthusiasts for specific physiological goals. BPC-157 and TB-500 are touted for injury recovery by stimulating new blood vessel growth; oxytocin is used in […]

Click here to view original web page at www.techspot.com